Anna Maria Tempczyk-Russell

This inventor holds 8 USPTO granted patents. Top assignees: Agouron Pharmaceuticals, Inc., Triad Therapeutics, Inc., Pfizer Healthcare Ireland. Active years: 2003-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anna Maria Tempczyk-Russell. Retrieved from https://idiyas.com/inventor/anna-maria-tempczyk-russell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 62.5

Average Co-Inventor Count = 5.4

ph-index = 4

Forward Citations = 180(Granted Patents)

Location History:

Ramona, CA (US) (2003 - 2006)
San Diego, CA (US) (2003 - 2023)

Company Filing History:

4 out of 174

Agouron Pharmaceuticals, Inc.

patents

2 out of 4

Triad Therapeutics, Inc.

patents

1 out of 1

Pfizer Healthcare Ireland

patent

4. 1 out of 1

Traid Therapeutics, Inc.

patent

Years Active: 2003-2023

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11780935 - Mutant antibodies and conjugation thereof (2023-10-10),

2. 7252931 - NMR-solve method for rapid identification of bi-ligand drug candidates (2007-08-07),

3. 7141587 - Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use (2006-11-28),

4. 6891044 - Indazole compounds and pharmaceutical compositions for Inhibiting protein kinases, and methods for their use (2005-05-10),

5. 6797460 - NMR-solve method for rapid identification of bi-ligand drug candidates (2004-09-28),

6. 6620828 - Thiazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use (2003-09-16),

7. 6620589 - NMR-solve method for rapid identification of Bi-ligand drug candidates (2003-09-16),

8. 6531491 - Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use (2003-03-11),

Title: Innovations of Anna Maria Tempczyk-Russell

Introduction

Anna Maria Tempczyk-Russell is a notable inventor based in Ramona, California. She has made significant contributions to the field of biotechnology, holding a total of eight patents. Her work focuses on the development of novel drug candidates and innovative polypeptide structures.

Latest Patents

Among her latest patents is a groundbreaking invention related to mutant antibodies and their conjugation. This invention involves a polypeptide comprising seven β-strands and a first α-helix, which are arranged to form distinct Ig domains. Another significant patent is the NMR-solve method for rapid identification of bi-ligand drug candidates. This method allows for the efficient screening of drug candidates that can bind to enzymes at both common and specificity ligand sites, enhancing the potential for high-affinity binding.

Career Highlights

Throughout her career, Anna has worked with prominent companies in the pharmaceutical industry, including Agouron Pharmaceuticals, Inc. and Triad Therapeutics, Inc. Her expertise in drug development has positioned her as a valuable asset in the field.

Collaborations

Anna has collaborated with notable professionals such as Steven Lee Bender and Allen Borchardt, contributing to her innovative research and development efforts.

Conclusion

Anna Maria Tempczyk-Russell's contributions to biotechnology through her patents and collaborations highlight her role as a leading inventor in her field. Her work continues to influence the development of new therapeutic solutions.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]